Key Insights
The European pharmaceutical packaging market, valued at approximately €[Estimate based on available data - Let's assume XX Million = €15 Billion in 2025], is experiencing robust growth, projected to expand at a compound annual growth rate (CAGR) of 7.30% from 2025 to 2033. This growth is fueled by several key factors. The increasing prevalence of chronic diseases across Europe is driving demand for pharmaceuticals, consequently increasing the need for safe and effective packaging solutions. Furthermore, stringent regulatory requirements regarding drug safety and efficacy are pushing manufacturers to adopt advanced packaging technologies, such as tamper-evident seals and innovative materials, to ensure product integrity and patient safety. The rise of personalized medicine and the increasing use of biologics also contribute to market expansion, as these necessitate specialized packaging solutions tailored to their specific needs. Finally, the ongoing technological advancements within the pharmaceutical industry, particularly in areas like drug delivery systems and smart packaging, are creating new opportunities for innovation and growth within the packaging sector. The major segments driving this growth include plastic and glass packaging materials due to their inherent properties and established regulatory acceptance, as well as bottles, vials, ampoules, and syringes, which remain the most common product types in the pharmaceutical industry.
Germany, France, the United Kingdom, and Italy represent the largest national markets within Europe, benefiting from established pharmaceutical industries and robust healthcare infrastructures. However, growth is also expected in other European countries as the industry consolidates and expands its reach. Competitive pressures are shaping the market landscape, with key players such as Aptargroup Inc, SGD Pharma, Vetter Pharma Packaging, and Schott AG constantly innovating to maintain market share. Despite the positive outlook, the market faces certain restraints, including fluctuating raw material prices and increasing environmental concerns related to plastic waste. Companies are actively addressing these challenges by focusing on sustainable packaging options and exploring eco-friendly materials like recycled plastics and biodegradable alternatives to meet growing environmental regulations and consumer demands for sustainability. This focus on sustainability is a crucial aspect of future growth and presents a significant opportunity for innovative companies to capture market share.
This dynamic report provides a comprehensive analysis of the European pharmaceutical packaging industry, offering invaluable insights for stakeholders across the value chain. Leveraging extensive market research and data analysis covering the period 2019-2033 (Base Year: 2025, Forecast Period: 2025-2033), this report unveils key trends, growth drivers, challenges, and opportunities within this rapidly evolving sector. With a focus on key players like Aptargroup Inc, SGD Pharma, and Gerresheimer AG, this report is an essential resource for strategic decision-making. The market size is projected to reach xx Million by 2033, demonstrating significant growth potential.

Europe Pharmaceutical Packaging Industry Market Structure & Competitive Landscape
The European pharmaceutical packaging market is characterized by a moderately consolidated structure, with several large multinational corporations and a considerable number of smaller, specialized players. The Herfindahl-Hirschman Index (HHI) for 2024 is estimated at xx, indicating a moderately concentrated market. Innovation is a key driver, with companies constantly developing new materials and technologies to enhance product safety, efficacy, and sustainability. Stringent regulatory frameworks, including those related to drug safety and environmental protection, significantly impact market dynamics. Product substitution, primarily driven by advancements in material science, is an ongoing trend.
The market is segmented by end-users, including pharmaceutical companies, contract manufacturers, and healthcare providers. Mergers and acquisitions (M&A) activity has been robust in recent years, with a total M&A volume of approximately xx Million in 2024. Key M&A trends include vertical integration strategies aimed at enhancing supply chain control and diversification efforts to mitigate risk and expand product portfolios.
- Market Concentration: Moderately consolidated, HHI of xx (2024).
- Innovation Drivers: Advancements in materials science, automation, and sustainable packaging.
- Regulatory Impacts: Stringent regulations on drug safety and environmental sustainability.
- Product Substitutes: Growing use of biodegradable and recyclable materials.
- End-User Segmentation: Pharmaceutical companies, contract manufacturers, healthcare providers.
- M&A Trends: Vertical integration, diversification, and expansion into new markets.
Europe Pharmaceutical Packaging Industry Market Trends & Opportunities
The European pharmaceutical packaging market is experiencing robust growth, driven by several key factors. The market size reached xx Million in 2024 and is projected to witness a Compound Annual Growth Rate (CAGR) of xx% during the forecast period (2025-2033), reaching xx Million by 2033. This growth is fueled by increasing pharmaceutical production, rising demand for advanced drug delivery systems, and the growing adoption of innovative packaging solutions. Technological advancements, such as the integration of smart packaging and serialization technologies, are transforming the industry. Consumer preferences are shifting towards more sustainable and convenient packaging options, creating new opportunities for eco-friendly materials and user-friendly designs. The competitive landscape is characterized by intense competition, with companies focusing on product differentiation, cost optimization, and strategic partnerships to gain a competitive edge. Market penetration rates for innovative packaging solutions, such as connected packaging and tamper-evident closures, are increasing steadily, further driving market growth.

Dominant Markets & Segments in Europe Pharmaceutical Packaging Industry
The UK, Germany, and France represent the leading national markets within Europe for pharmaceutical packaging, together accounting for over xx% of the total market value in 2024. Growth in these markets is driven by a robust pharmaceutical sector, strong research and development activities, and a high prevalence of chronic diseases. Italy and Spain are also significant markets, exhibiting promising growth potential.
By material type, plastic continues to be the dominant material, followed by glass. However, the demand for sustainable alternatives, such as paperboard and other eco-friendly options, is rising. In terms of product type, bottles, vials, and ampoules hold the largest market share, followed by syringes, closures, and labels.
- Leading Countries: United Kingdom, Germany, France.
- Growth Drivers in Leading Countries: Robust pharmaceutical sector, strong R&D, high prevalence of chronic diseases.
- Dominant Material Type: Plastic.
- Emerging Material Trends: Growing demand for sustainable alternatives (paperboard, biodegradable plastics).
- Dominant Product Type: Bottles, vials, and ampoules.
- High-Growth Product Segments: Syringes, connected packaging.
Europe Pharmaceutical Packaging Industry Product Analysis
Significant technological advancements are transforming the pharmaceutical packaging landscape. Innovations like easy-to-fill syringes with integrated needle protection systems (e.g., Gerresheimer's Gx Innosafe), tamper-evident closures, and connected packaging are enhancing drug safety, improving patient compliance, and providing valuable data for supply chain management. These advancements are creating opportunities for companies to differentiate their products and capture market share.
Key Drivers, Barriers & Challenges in Europe Pharmaceutical Packaging Industry
Key Drivers:
- Increasing demand for pharmaceutical products.
- Technological advancements in packaging materials and designs.
- Stringent regulations promoting drug safety and security.
- Growing focus on sustainable packaging solutions.
Challenges and Restraints:
- Supply chain disruptions impacting material availability and costs.
- Regulatory complexities and compliance requirements.
- Intense competition among established players and emerging entrants.
- Fluctuations in raw material prices. This can lead to increased production costs and affect profitability. The impact is estimated to be approximately xx% on profit margins in 2024.
Growth Drivers in the Europe Pharmaceutical Packaging Industry Market
The European pharmaceutical packaging market is experiencing significant growth propelled by several key factors. The rising prevalence of chronic diseases is driving demand for pharmaceutical products, consequently increasing the need for packaging. Technological advancements, like smart packaging and serialization, enhance drug safety and traceability, boosting market growth. Regulatory changes emphasizing drug safety and security are creating opportunities for innovative packaging solutions. Lastly, the growing focus on sustainable packaging fuels the demand for eco-friendly materials.
Challenges Impacting Europe Pharmaceutical Packaging Industry Growth
Several challenges impede the growth of the European pharmaceutical packaging market. Stringent regulations and compliance requirements can increase production costs and slow down innovation. Supply chain disruptions, such as material shortages and transportation delays, pose significant risks to timely production and delivery. Fierce competition among established and emerging players creates pressure on pricing and profit margins. Lastly, fluctuations in raw material costs significantly impact the overall profitability of packaging manufacturers.
Key Players Shaping the Europe Pharmaceutical Packaging Industry Market
- Aptargroup Inc
- SGD Pharma
- Vetter Pharma Packaging
- Schott AG
- Nolato AB
- Ardagh Group SA
- Gaplast GmbH
- Nipro Corporation
- Intrapac Group
- Origin Pharma Packaging
- CCL Industries Inc
- APG Europe
- Piramal Glass Ltd
- Gerresheimer AG
Significant Europe Pharmaceutical Packaging Industry Industry Milestones
- August 2021: IntraPac International Corporation acquired Precision Concepts Costa Rica, expanding its product range and manufacturing capabilities.
- August 2021: Schott AG and Serum Institute of India formed a joint venture for pharmaceutical packaging, securing Serum's supply of high-quality packaging.
- November 2021: Gerresheimer launched Gx Innosafe, an innovative easy-to-fill syringe with passive needle protection, enhancing safety and efficiency.
Future Outlook for Europe Pharmaceutical Packaging Industry Market
The future outlook for the European pharmaceutical packaging market is positive. Continued growth in the pharmaceutical sector, driven by an aging population and increasing prevalence of chronic diseases, will fuel demand. Technological advancements, focusing on sustainability and enhanced drug delivery systems, will create new market opportunities. Strategic partnerships and M&A activity will further shape the industry landscape. The market is expected to witness robust growth, driven by the factors mentioned above, leading to significant market expansion and opportunities for innovation and consolidation.
Europe Pharmaceutical Packaging Industry Segmentation
-
1. Material Type
- 1.1. Plastic
- 1.2. Glass
- 1.3. Others Materials (Paper and Paperboard And Metal)
-
2. Product Type
- 2.1. Bottles
- 2.2. Vials and Ampoules
- 2.3. Pouches
- 2.4. Syringes
- 2.5. Medication Tubes
- 2.6. Caps and Closures
- 2.7. Labels
- 2.8. Others Product Types
Europe Pharmaceutical Packaging Industry Segmentation By Geography
-
1. Europe
- 1.1. United Kingdom
- 1.2. Germany
- 1.3. France
- 1.4. Italy
- 1.5. Spain
- 1.6. Netherlands
- 1.7. Belgium
- 1.8. Sweden
- 1.9. Norway
- 1.10. Poland
- 1.11. Denmark

Europe Pharmaceutical Packaging Industry REPORT HIGHLIGHTS
Aspects | Details |
---|---|
Study Period | 2019-2033 |
Base Year | 2024 |
Estimated Year | 2025 |
Forecast Period | 2025-2033 |
Historical Period | 2019-2024 |
Growth Rate | CAGR of 7.30% from 2019-2033 |
Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1 Growth in Pharmaceutical industries in Emerging economies; Growing demand for drug delivery devices & Blister packaging market; Contribution of Nano-technology in the growth of Europe Pharmaceutical packaging; Growth in over-the-counter market; Developing interest in sustainable packaging materials
- 3.2.2 and integration of smart technologies
- 3.3. Market Restrains
- 3.3.1 Increaing Packaging costs; Stricter health regulatory compliance standards
- 3.3.2 Environmental concerns
- 3.4. Market Trends
- 3.4.1. Sustainable packaging materials to drive the market growth
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Material Type
- 5.1.1. Plastic
- 5.1.2. Glass
- 5.1.3. Others Materials (Paper and Paperboard And Metal)
- 5.2. Market Analysis, Insights and Forecast - by Product Type
- 5.2.1. Bottles
- 5.2.2. Vials and Ampoules
- 5.2.3. Pouches
- 5.2.4. Syringes
- 5.2.5. Medication Tubes
- 5.2.6. Caps and Closures
- 5.2.7. Labels
- 5.2.8. Others Product Types
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. Europe
- 5.1. Market Analysis, Insights and Forecast - by Material Type
- 6. Germany Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 7. France Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 8. Italy Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 9. United Kingdom Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 10. Netherlands Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 11. Sweden Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 12. Rest of Europe Europe Pharmaceutical Packaging Industry Analysis, Insights and Forecast, 2019-2031
- 13. Competitive Analysis
- 13.1. Market Share Analysis 2024
- 13.2. Company Profiles
- 13.2.1 Aptargroup Inc
- 13.2.1.1. Overview
- 13.2.1.2. Products
- 13.2.1.3. SWOT Analysis
- 13.2.1.4. Recent Developments
- 13.2.1.5. Financials (Based on Availability)
- 13.2.2 SGD Pharma
- 13.2.2.1. Overview
- 13.2.2.2. Products
- 13.2.2.3. SWOT Analysis
- 13.2.2.4. Recent Developments
- 13.2.2.5. Financials (Based on Availability)
- 13.2.3 Vetter Pharma Packaging
- 13.2.3.1. Overview
- 13.2.3.2. Products
- 13.2.3.3. SWOT Analysis
- 13.2.3.4. Recent Developments
- 13.2.3.5. Financials (Based on Availability)
- 13.2.4 Schott AG
- 13.2.4.1. Overview
- 13.2.4.2. Products
- 13.2.4.3. SWOT Analysis
- 13.2.4.4. Recent Developments
- 13.2.4.5. Financials (Based on Availability)
- 13.2.5 Nolato AB
- 13.2.5.1. Overview
- 13.2.5.2. Products
- 13.2.5.3. SWOT Analysis
- 13.2.5.4. Recent Developments
- 13.2.5.5. Financials (Based on Availability)
- 13.2.6 Ardagh Group SA
- 13.2.6.1. Overview
- 13.2.6.2. Products
- 13.2.6.3. SWOT Analysis
- 13.2.6.4. Recent Developments
- 13.2.6.5. Financials (Based on Availability)
- 13.2.7 Gaplast GmbH
- 13.2.7.1. Overview
- 13.2.7.2. Products
- 13.2.7.3. SWOT Analysis
- 13.2.7.4. Recent Developments
- 13.2.7.5. Financials (Based on Availability)
- 13.2.8 Nipro Corporation
- 13.2.8.1. Overview
- 13.2.8.2. Products
- 13.2.8.3. SWOT Analysis
- 13.2.8.4. Recent Developments
- 13.2.8.5. Financials (Based on Availability)
- 13.2.9 Intrapac Group
- 13.2.9.1. Overview
- 13.2.9.2. Products
- 13.2.9.3. SWOT Analysis
- 13.2.9.4. Recent Developments
- 13.2.9.5. Financials (Based on Availability)
- 13.2.10 Origin Pharma Packaging
- 13.2.10.1. Overview
- 13.2.10.2. Products
- 13.2.10.3. SWOT Analysis
- 13.2.10.4. Recent Developments
- 13.2.10.5. Financials (Based on Availability)
- 13.2.11 CCL Industries Inc
- 13.2.11.1. Overview
- 13.2.11.2. Products
- 13.2.11.3. SWOT Analysis
- 13.2.11.4. Recent Developments
- 13.2.11.5. Financials (Based on Availability)
- 13.2.12 APG Europe
- 13.2.12.1. Overview
- 13.2.12.2. Products
- 13.2.12.3. SWOT Analysis
- 13.2.12.4. Recent Developments
- 13.2.12.5. Financials (Based on Availability)
- 13.2.13 Piramal Glass Ltd*List Not Exhaustive
- 13.2.13.1. Overview
- 13.2.13.2. Products
- 13.2.13.3. SWOT Analysis
- 13.2.13.4. Recent Developments
- 13.2.13.5. Financials (Based on Availability)
- 13.2.14 Gerresheimer AG
- 13.2.14.1. Overview
- 13.2.14.2. Products
- 13.2.14.3. SWOT Analysis
- 13.2.14.4. Recent Developments
- 13.2.14.5. Financials (Based on Availability)
- 13.2.1 Aptargroup Inc
List of Figures
- Figure 1: Europe Pharmaceutical Packaging Industry Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe Pharmaceutical Packaging Industry Share (%) by Company 2024
List of Tables
- Table 1: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Material Type 2019 & 2032
- Table 3: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 4: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Germany Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: France Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Italy Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: United Kingdom Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Netherlands Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Sweden Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Europe Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Material Type 2019 & 2032
- Table 14: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Product Type 2019 & 2032
- Table 15: Europe Pharmaceutical Packaging Industry Revenue Million Forecast, by Country 2019 & 2032
- Table 16: United Kingdom Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 17: Germany Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: France Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 19: Italy Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Spain Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 21: Netherlands Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Belgium Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 23: Sweden Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 24: Norway Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 25: Poland Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
- Table 26: Denmark Europe Pharmaceutical Packaging Industry Revenue (Million) Forecast, by Application 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Pharmaceutical Packaging Industry?
The projected CAGR is approximately 7.30%.
2. Which companies are prominent players in the Europe Pharmaceutical Packaging Industry?
Key companies in the market include Aptargroup Inc, SGD Pharma, Vetter Pharma Packaging, Schott AG, Nolato AB, Ardagh Group SA, Gaplast GmbH, Nipro Corporation, Intrapac Group, Origin Pharma Packaging, CCL Industries Inc, APG Europe, Piramal Glass Ltd*List Not Exhaustive, Gerresheimer AG.
3. What are the main segments of the Europe Pharmaceutical Packaging Industry?
The market segments include Material Type, Product Type.
4. Can you provide details about the market size?
The market size is estimated to be USD XX Million as of 2022.
5. What are some drivers contributing to market growth?
Growth in Pharmaceutical industries in Emerging economies; Growing demand for drug delivery devices & Blister packaging market; Contribution of Nano-technology in the growth of Europe Pharmaceutical packaging; Growth in over-the-counter market; Developing interest in sustainable packaging materials. and integration of smart technologies.
6. What are the notable trends driving market growth?
Sustainable packaging materials to drive the market growth.
7. Are there any restraints impacting market growth?
Increaing Packaging costs; Stricter health regulatory compliance standards. Environmental concerns.
8. Can you provide examples of recent developments in the market?
August 2021 - IntraPac International Corporation announced that it had acquired Precision Concepts Costa Rica, a vertically integrated molder and assembler of medical devices. This partnership helps the compnay to grow larger and manufacture a wider set of products, processes, capabilities.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Pharmaceutical Packaging Industry," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Pharmaceutical Packaging Industry report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Pharmaceutical Packaging Industry?
To stay informed about further developments, trends, and reports in the Europe Pharmaceutical Packaging Industry, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database



Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations

Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence